CN Patent

CN111803470A — 含有右酮洛芬或其药用盐的凝胶贴膏基质及其制备方法

Assigned to HUNAN PUDAO MEDICAL TECHNOLOGY CO LTD · Expires 2020-10-23 · 6y expired

What this patent protects

本发明公开了一种含有右酮洛芬或其药用盐的凝胶贴膏基质及其制备方法,凝胶贴膏基质,以重量百分比计,包含:右酮洛芬或其药用盐0.3~1.2%,高分子亲水凝胶骨架材料5~10%,保湿剂20~40%,增黏剂1~5%,填充剂2~5%,表面活性剂0.5~2%,pH调节剂0.2~1%,交联剂0.01~0.6%,交联调节剂0.01~0.2%,溶剂40~55%,其中,保湿剂为聚乙二醇和山梨醇。本发明通过改善凝胶贴膏基质的体系,采用聚乙二醇和山梨醇联合作为保湿剂,减少了因常用保湿剂甘油与丙烯酸类非甾体抗炎药发生酯化反应而使有关物质增加及含量下降的风险,同时提高了凝胶贴膏基质…

USPTO Abstract

本发明公开了一种含有右酮洛芬或其药用盐的凝胶贴膏基质及其制备方法,凝胶贴膏基质,以重量百分比计,包含:右酮洛芬或其药用盐0.3~1.2%,高分子亲水凝胶骨架材料5~10%,保湿剂20~40%,增黏剂1~5%,填充剂2~5%,表面活性剂0.5~2%,pH调节剂0.2~1%,交联剂0.01~0.6%,交联调节剂0.01~0.2%,溶剂40~55%,其中,保湿剂为聚乙二醇和山梨醇。本发明通过改善凝胶贴膏基质的体系,采用聚乙二醇和山梨醇联合作为保湿剂,减少了因常用保湿剂甘油与丙烯酸类非甾体抗炎药发生酯化反应而使有关物质增加及含量下降的风险,同时提高了凝胶贴膏基质的保湿性能和制剂储存稳定性。

Drugs covered by this patent

Patent Metadata

Patent number
CN111803470A
Jurisdiction
CN
Classification
Expires
2020-10-23
Drug substance claim
No
Drug product claim
No
Assignee
HUNAN PUDAO MEDICAL TECHNOLOGY CO LTD
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.